Condition
Lung Cancer|Malignant Mesothelioma|Pancreatic Cancer|Sarcoma
Estimated Enrollment: null
Age Group: 13 Years and older (Child, Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: SALMEDIX-SDX-102-01|MSKCC-03029|CDR0000304677
Study First Received: June 5, 2003
Last Updated: June 25, 2013
Estimated Primary Completion Date: December 2005
Primary Outcome Measures:
Sponsors and Collaborators:
Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI)
Website Link: https://ClinicalTrials.gov/show/NCT00062283
